All In Biotech

Drug Trial Radar · NCT06475846

A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults

A Evaluate HRS5580 for Injection for Prevention of Postoperative Nausea and Vomiting Efficacy and Safety of Ⅱ Period, Randomized, Multicenter, Dose of Exploration, Positive Control, Placebo-controlled, Double-blind, Double Simulation Trials

Last checked: Nov 19, 2026Latest source record: Jan 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 235 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

235

Actual

Start

Jun 25, 2024

Primary completion

Oct 29, 2024

Study completion Oct 29, 2024

Sponsor

Sponsor type
Industry
First posted
Jun 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is being conducted to evaluate the efficacy, and safety of HRS5580 for preventing of postoperative nausea and vomiting in adults. To explore the reasonable dosage of HRS5580 for postoperative nausea and vomiting.

Conditions

  • Preventing of Postoperative Nausea and Vomiting in Adults

Interventions

  • HRS5580Drug

    HRS5580; low dose

  • HRS5580Drug

    HRS5580; middle dose

  • HRS5580Drug

    HRS5580; middle dose

  • OndansetronDrug

    Ondansetron

  • blank preparationDrug

    blank preparation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. No vomiting rate within 72 hours after extubationTime frame: at 72 hours after extubation

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Third Xiangya Hospital of Central South University

    Changsha, Hu'nan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.